Zobrazeno 1 - 10
of 331
pro vyhledávání: '"McTavish, D."'
Publikováno v:
Women in Management Review, 2007, Vol. 22, Issue 5, pp. 353-370.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/09649420710761437
Publikováno v:
Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS179-S179. 1p.
Publikováno v:
In Journal of Cystic Fibrosis 2021 20 Supplement 1:S104-S104
Autor:
MCTAVISH, D. J.1 mctavish@ryerson.ca, OKOUNEVA, G.2 gokounev@ryerson.ca, ENGLISH, C. E.3 cenglish@neptec.com
Publikováno v:
International Journal of Shape Modeling. Jun/Dec2009, Vol. 15 Issue 1/2, p45-76. 32p. 1 Color Photograph, 10 Diagrams, 1 Chart, 3 Graphs.
Autor:
Morrison, L., McTavish, D.
Publikováno v:
In Journal of Cystic Fibrosis June 2020 19 Supplement 2:S11-S11
Autor:
McTavish D
Publikováno v:
Scottish Medical Journal. 45:155-158
Management of the health service in Scotland and England, has since its creation, shown both divergence and congruence. In the initial decades in Scotland the executive hospital boards (which contained strong medical professional membership) and cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e13daf52402da7d6d4dc81a94e99dd4
https://doi.org/10.1177/003693300004500511
https://doi.org/10.1177/003693300004500511
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Drugsaging. 5(2)
Idebenone is a benzoquinone compound which has been investigated in elderly patients with dementia. Its precise mechanism(s) of action remains unknown, but in vitro and in vivo studies suggest the drug may diminish nerve cell damage due to ischaemia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a0b321ac3a0bae206fbf93560c4bec
https://pubmed.ncbi.nlm.nih.gov/7981485
https://pubmed.ncbi.nlm.nih.gov/7981485
Publikováno v:
Drugs. 46(2)
Tramadol is a centrally acting analgesic which possesses opioid agonist properties and activates monoaminergic spinal inhibition of pain. It may be administered orally, rectally, intravenously or intramuscularly. In patients with moderate to severe p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d593a6e954522fe139ec2b27d82a5930
https://pubmed.ncbi.nlm.nih.gov/7691519
https://pubmed.ncbi.nlm.nih.gov/7691519